Palynziq

Active Ingredient(s): Pegvaliase-pqpz
FDA Approved: * May 24, 2018
Pharm Company: * BIOMARIN PHARM
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Palynziq 2.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 68135-058
Labeler:
Biomarin Pharmaceutical Inc.
Palynziq 20 mg/ml Subcutaneous Injection, Solution
NDC: 68135-673
Labeler:
Biomarin Pharmaceutical Inc.
Palynziq 10 mg/.5ml Subcutaneous Injection, Solution
NDC: 68135-756
Labeler:
Biomarin Pharmaceutical Inc.